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The increasing prevalence of obesity is accompanied by a rising incidence in
metabolic syndrome and related pathologies such as non-alcoholic fatty liver disease.
Macrophages are hypothesized to play central roles in these diseases, through their role
as inflammatory mediators and as such are thought to be potential targets for future
therapies. Recently, single cell technologies have revealed significant heterogeneity within
the macrophage pool in both liver and adipose tissue in obesity. Thus current efforts
are focused on dissecting this heterogeneity and understanding the distinct functions
of the individual subsets. In this review, we discuss the current knowledge regarding
macrophage heterogeneity, ontogeny and functions in the context of obese adipose
tissue and fatty liver disease and attempt to align the distinct populations described
to date.
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INTRODUCTION
The transition to a more sedentary lifestyle coupled with a higher caloric intake has led to an
enormous rise in incidences of obesity over the past decades. Simultaneously, this has led to a
dramatic increase in the number of patients suffering from numerous obesity-linked metabolic
disorders including insulin resistance and type 2 diabetes, cardiovascular disease and non-alcoholic
fatty liver disease (NAFLD). In fact, since 1975, obesity levels have almost tripled worldwide and
according to the World Health Organization (WHO) this accounted for ∼8% of deaths in 2017
largely due to cardiovascular disease. Chronic low-grade inflammation has been suggested to be
related to many of the co-morbidities of obesity including type 2 diabetes, NAFLD, steatohepatitis
and cardiovascular disease [reviewed in (1)], leading to the concept of “metainflammation” (2).
This is characterized by abnormal cytokine production, activation of inflammatory signaling
pathways and increased acute phase reactants (3). Macrophages, as cells of the innate immune
system, are thought to contribute significantly to metainflammation across obese tissues [reviewed
in (4)]. Here, macrophages have been suggested to alter their phenotype toward a more
pro-inflammatory profile and this has been proposed to be detrimental in the long-term, driving
fibrosis and tissue damage (5, 6). More recently, the idea that these macrophages may be generated
as (initially) a tissue protective mechanism, to deal with the increased lipid load has also been
proposed (7). In recent years, it has become evident that there are multiple subsets of macrophages
present in both obese adipose tissue and the fatty liver that may contribute differently to the
pathogenesis of disease. What remains unclear is whether these represent an altered phenotype
of tissue-resident macrophages (Res-macs) or newly recruited populations of macrophages. In the
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latter case how these recruited macrophages relate to their tissue-
resident counterparts also remains unclear. Answering these
questions will be crucial to deciphering the different functions
of the macrophages and understanding how best to target
them therapeutically. While our understanding of macrophage
heterogeneity, has been greatly improved through the use of
single cell technologies including single cell RNA sequencing
(scRNA-seq), there is often little consensus between studies with
authors often using expression of different genes to identify
subsets and giving the subsets identified distinct names. In this
review, we will discuss what is currently known regarding the
macrophage subsets present in the liver in non-alcoholic fatty
liver disease and in obese adipose tissue, their origins and their
specific functions. In addition, where possible, we attempt to
align the different populations identified to date. For the most
part the studies discussed here have been conducted in murine
models unless stated otherwise (Table S1).
TISSUE-RESIDENT MACROPHAGES
Under homeostatic conditions, tissue-resident macrophages
(Res-macs) represent the majority of macrophages in the body.
These are generated alongside their tissue of residence, typically
during embryogenesis and as such derive, at least initially, from
embryonic progenitors including yolk-sac macrophages and fetal
liver monocytes [reviewed extensively in (8–10)]. As the tissues
grows in the 1st weeks of life, bone-marrow derived monocytes
can also engraft in some tissues and generate Res-macs (8, 11).
In most tissues, once organ growth has ceased, the Res-macs
are maintained independently from any significant input from
circulating progenitors, but rather through local proliferation of
existing macrophages, although there are a few exceptions to this
including the gut, dermis, heart and lung interstitial macrophages
which are continuously replaced from the BM throughout life
[reviewed in (8, 9, 12)]. Additionally, in old-age, BM monocytes
may also start to contribute again to the Res-mac pools in some
tissues, with a slight increase in BM-derived macrophages being
observed in the spleen and peritoneal cavity between 36 and 46
weeks after tamoxifen labeling (13). Notably, in the lung and liver,
the specific origin of the Res-macs, termed alveolar macs (Res-
AMs) and Kupffer cells (Res-KCs) respectively, whether yolk-sac
macrophages, fetal liver monocytes or bone marrow monocytes,
does not appear to significantly affect the transcriptional profile
of these macrophages or their ability to self-renew provided
they are generated under homeostatic conditions (11, 14). This
conditioning of progenitors enabling the development of Res-
macs under homeostatic conditions, is proposed to result from
the interactions between the progenitors/macrophages and the
specific cells in their local environment or “niche” including
stromal cells, endothelial cells and structural cells (8, 15)
and indeed crosstalk between macrophages and fibroblasts has
already been demonstrated in vitro under both healthy and
fibrotic conditions (16, 17), while in vivo, many of the signals
driving monocyte recruitment and differentiation into Kupffer
cells following depletion have already been elucidated including
Il1β, TNFα, DLL4, NOTCH, LXRα, and BMPs (18, 19).
Regarding their functions, Res-macs fulfill central roles
in tissue homeostasis and immunity through their constant
surveillance and their ability to clear foreign substances, dead
cells and debris. This clearance is mediated through recognition
of pathogen-associated molecular patterns (PAMPs) or damage-
associated molecular patterns (DAMPs) by pattern recognition
receptors (PRRs) present on their cell surface. In addition to
physically clearing the tissue of pathogens, dead/dying cells and
other debris, Res-macs can also express multiple cytokines which
contribute to the activation of other innate immune cells and
the adaptive immune system. Notably, through their unique
transcriptomic profiles imprinted by signals from the local niche
(8, 15), Res-macs are also proposed to play additional roles in
maintaining tissue homeostasis, performing several “accessory”
functions depending on the needs of their tissue of residence (20).
These tissue-specific transcriptional profiles have been shown to
be driven through expression of “master” transcription factors,
which are imprinted in the macrophages by signals from their
local niche (21, 22). For example, the transcriptional profiles of
Res-KCs in the liver and Res-AMs in the alveolar space of the lung
are both enriched for genes associated with a lipid metabolism
function (21, 23), with the lipid metabolism profile of KCs being
driven at least in part through expression of LXRα (23), which is
imprinted on KCs by liver sinusoidal endothelial cells and hepatic
stellate cells (18, 19). Similarly, Res-macs in the liver and spleen
are enriched for genes necessary for iron processing, a function
regulated by the master transcription factor SpiC (23–25).
With the identification of the substantial role played by
the niche in regulating Res-mac gene expression and hence
functionality, one of the key questions in the macrophage
field today is how does the niche change in inflammation and
how does this impact Res-mac survival and function? Notably,
a population of microglia with a distinct transcriptional and
functional profile have recently been described in aged mice
(20 months). These microglia contain lipid droplets and were
hence termed lipid droplet-containing aged microglia (LDAMs)
(26). As there is limited input of HSCs to the microglia pool
46 weeks after tamoxifen administration (13) these LDAMs
are suggested to be a population of Res-microglia, suggesting
that Res-macs may indeed respond to changes in their local
environment as occurs in aging or inflammation. However, as
the origin of LDAMs was not formally tested in this study, it
remains to be seen if these are indeed altered Res-macs or a newly
recruited population (26). Nevertheless, understanding how the
niche changes and how this may alter themacrophages is relevant
question especially in the context of obesity and metabolic
disease, where, for example, changes in hepatic stellate cells and
myofibroblasts in the liver have been already been reported in
NASH and fibrosis in both mouse and human samples (27, 28).
RECRUITED MACROPHAGES
Alongside Res-macs, when homeostasis is perturbed, for example
due to inflammation and/or infection, bone marrow monocytes
are recruited to the tissue, where they subsequently differentiate
into macrophages. In some instances these cells represent a
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short-lived transient population that are recruited during the
inflammation/infection but are typically lost a few days after
return to homeostasis (29–32), thus from herein these will be
termed “temporary macrophages” (Temp-macs). However, bone
marrow monocytes can also engraft and become long-lived
resident macs under non-homeostatic conditions (32–36). When
this happens in the brain due to genetic models or irradiation
substantial differences are observed between the profiles of these
recruited Res-macs compared with the embryonically-derived
Res-microglia, including expression of the microglia-identity
gene Sall1 (33–35). Thus, we propose to call these Res-macs
recruited under non-homeostatic conditions inflammatory Res-
macs (infRes-macs).Whether these differences in brainmicroglia
are due to timing and hence a potentially altered niche (for
example adulthood vs. embryo) or due to intrinsic differences in
the progenitors remains to be investigated. Notably, BM-derived
KCs engrafting after genotoxic injury also display some (albeit
minor) differences in their transcriptional programs compared
with those engrafting under homeostatic conditions following
DT mediated depletion (11, 37), suggesting the altered niche
may be the most important factor at play. In the lung in
the context of influenza infection, Res-AMs were found to be
largely unchanged by the virus but reduced in numbers, which
led to the development of BM-derived infRes-AMs during the
infection with distinct functions, transcription and epigenetic
profiles as compared with the Res-AMs (36). Notably, with time
spent in the lung niche following recovery from infection, these
differences were gradually lost and thus the infRes-AMs more
closely resembled the Res-AMs with time (36). In the liver in a
model of NASH, we also observed BM-monocytes differentiating
into infRes-KCs that were maintained for at least 4 weeks after
return to homeostasis (32). However, how similar these infRes-
KCs were to the Res-KCs was not investigated (32) and remains
an open question. Given the observation that infRes-macs can
have significantly altered profiles and hence altered functionality
compared with Res-macs, these macs should be discriminated
from one another. This could be especially important in disease
settings where one might aim to promote Res-macs over
newly recruited infRes-macs or vice versa depending on their
specific functions.
The recruitment of both Temp-macs and infRes-macs
to supplement the original Res-macs in inflammation raises
multiple questions. For example, why do we recruit macrophages
in non-homeostatic conditions? Does this mean that Res-macs
are not plastic enough to be able to deal with the insult? Do
Res-macs alter their profiles as has been previously suggested
or are changes within the total macrophage pool due solely to
the recruitment of Temp-macs and infRes-macs? Indeed the
influenza study would suggest the original Res-macs are not
substantially altered by the virus but rather cannot maintain
their numbers and hence require input from the BM (36). Is
this true in obese tissues? Are infRes-macs required to maintain
macrophage numbers as some Res-macs are lost and proliferation
rates are not sufficient to replenish the pool? If so, how similar
are these infRes-macs to their original Res-mac counterparts?
Moreover, how distinct are infRes-macs and Temp-macs? Do
these represent distinct populations of macrophages entering
the tissue or can some Temp-macs also become infRes-macs?
In the context of obesity, it will be important to address these
questions to understand (i) which subsets are important in
the pathology, (ii) which signals drive the recruitment and
differentiation of the different subsets, and (iii) how we could
target the required subsets therapeutically. Crucially, it will be
important to understand which subsets are found across multiple
labs, models, and indeed species to be able to understand which
populations could be clinically relevant. With this in mind, below
we will discuss the current knowledge regarding the distribution
and origins of different macrophages subsets and their functions
in obese tissues and attempt to align the subsets identified by
different groups. However, as will become clear, this is not always
straight-forward and as a result there are still many unanswered
questions regarding these cells in obesity.
MACROPHAGE SUBSETS IN NAFLD AND
NASH
NAFLD is the hepatic manifestation of metabolic syndrome.
It currently represents the most common etiology of chronic
liver inflammation in the western world. Due to the lack of
treatment options available, it is predicted to be the primary
reason for liver transplantation in the western world by 2030
(38–41). The current lack of therapies for patients with NAFLD
stems from the fact that NAFLD is a complex disease, consisting
of different stages ranging from simple steatosis (retention of fat
in the liver) to non-alcoholic steatohepatitis (NASH), cirrhosis
and even hepatocellular carcinoma (HCC). While patients with
simple steatosis are largely asymptomatic, the progression to
NASH, fibrosis and eventual cirrhosis leads to the need for liver
transplantation. Notably, this progression fromNAFLD toNASH
does not occur in all patients and the mechanisms underlying
this transition remain largely unknown. It has been proposed
that multiple “hits” coming from the gut and adipose tissue may
account for this progression (42), with one of the hits being
the ensuing inflammation potentially driven by macrophages in
response to the increased lipid load and hepatocellular death.
During steady state, the predominant macrophage population
present in the liver is the resident Kupffer Cells (Res-KCs). They
are one of the largest populations of Res-macs present in the
body and reside with part of their body in the liver sinusoids
where they are in close contact with liver sinusoidal endothelial
cells (LSECs) and part in the liver parenchyma where they are in
close contact with hepatic stellate cells (HSCs) and hepatocytes
(19). In mice, KCs can be identified by their specific expression
of the C-type lectin, CLEC4F (11). In addition, once resident
in the liver, KCs also express TIM4 and thus the combination
of CLEC4F and TIM4 is very useful to discriminate between
Res-KCs (CLEC4F+TIM4+) and recently recruited KCs, on their
way to becoming resident (CLEC4F+TIM4−) and Temp-macs
(CLEC4F−TIM4−) that can either differentiate into KCs or be
lost from the tissue upon return to tissue homeostasis (11, 32). In
humans, the best markers of Res-KCs compared with the other
mac populations present in the liver are still being elucidated,
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although CD163, TIMD4, and MARCO expression have been
suggested to identify Res-KCs (28, 43).
In the context of NAFLD, Res-KCs have been proposed to
drive the progression from NAFLD to NASH through their
role as inflammatory mediators [recently reviewed in (6)].
This hypothesis stems from studies suggesting the balance
between M2- and M1-like hepatic macrophages is altered
in NAFLD and that promoting more M2-like macrophages
may be beneficial in NAFLD (44–48). In addition, studies
depleting macrophages using models including LysM-driven
genetic models and clodronate liposomes have further fueled
the hypothesis that Res-KCs drive the development of hepatic
steatosis, insulin resistance, liver damage and inflammation (49–
53). However, two main findings are now altering this line of
thinking. Firstly, it is now clear that the M1/M2 polarization
states are not sufficient to describe the complex milieu of signals
which imprint macrophage phenotypes and functions in vivo
(54). Indeed, under homeostatic conditions, the transcriptional
profile of Res-KCs and other tissue Res-macs do not resemble
those of either M1 or M2 macrophages (Figure 1, Table S2).
Moreover, it has become clear that Res-KCs are not the only
population of macrophages in the fatty liver, with a number of
Temp-macs being recruited from the bone marrow in a CCR2-
dependent manner that are also thought to play a role in the
progression to steatohepatitis and fibrosis (56–58). Thus, it is
not yet clear if Temp-macs or Res-KCs are contributing to the
phenotypes observed when total macrophages are manipulated
using such non-KC-specific models as described above and hence
the exact roles played by Res-KCs in NAFLD/NASH remain to
be understood. In addition, in mice fed a methionine-choline
deficient (MCD) diet to induce NASH, we demonstrated that
CLEC4F− Temp-macs are recruited to the liver and that some
of these give rise to CLEC4F+TIM4− infRes-macs (32). Thus,
potentially, there could be at least 3 distinct subsets of macs with
different transcriptional profiles and functions inNAFLD/NASH.
However, as mice fed the MCD diet develop NASH symptoms
but do not gain weight (32), whether these infRes-Macs are also
found in more biologically relevant models of NAFLD/NASH
or indeed in human NAFLD/NASH remains to be seen as
discussed below.
With these caveats of earlier studies in mind, what have we
learnt in recent years regarding the subsets and roles of liver
macrophages in NAFLD/NASH? Intriguingly and contrary to
the widely accepted hypothesis, a recent study has found that
neither obese human macrophages nor high-fat diet fed (12
weeks) murine liver macrophages (purified as adherent cells
following tissue digestion, percoll gradient and plating) altered
their expression of a standard panel of activation associated genes
including Tnfa, Il1b, Il6, Il10, Tgfb1, Ccl2, Ccl5, Itgax, Cd80,
Socs3, Chil3, Arg1, or Egr2 (59). This therefore raises the question
whether Res-KCs do respond to the fatty liver environment and
mediate the inflammation as originally proposed or if perhaps
they behave more like the Res-AMs in the lung during influenza
infection (36). However, as here there was no discrimination
between Res-KCs and other liver macs (59) it is difficult to draw
any conclusions regarding the roles of these cells, perhaps Res-
KCs are not activated or perhaps they are but their numbers are
FIGURE 1 | No overt M1 or M2 activation profile in tissue resident
macrophages in homeostatic conditions. Expression of gene modules
associated with M1 (module 7, 8, 9) and M2 (module 13, 14, 15) human
macrophages (55) by microglia, splenic macrophages, colonic macrophages,
Kupffer cells and Alveolar macrophages isolated from mice under homeostatic
conditions (23). Expression of core identity genes of each tissue resident
macrophage population (23) were also visualized as a control (Genes
associated with each module and population can be found in Table S2). To
generate the heatmap, mouse gene symbols were used as input for the AUCell
R package. In brief, AUCell allows you to identify cells with active gene sets
(e.g., signatures, gene modules) in single cell RNA-seq data by first ranking the
genes from highest to lowest value per cell. Next, area under the curve (AUC)
is calculated to determine whether the gene set is enriched at the top of the
gene-ranking for each cell. The output is a matrix with an AUC score for each
gene set in each cell. For the heatmap we calculated the mean AUC of all cells.
reduced in NAFLD leading to the majority of total macs being
Temp-macs without an overtly activated profile. Thus, further
work is required to answer these questions.
The recent advances in scRNA-seq studies have started to
shed light on the heterogeneity of macrophages present in the
NAFLD/NASH liver. One recent study employing scRNA-seq of
CD45+Ly6G− myeloid cells isolated from mice fed a western
diet supplemented with fat, sugar and cholesterol for 16 weeks
identified 3 distinct clusters of recruited macrophages (termed
Mo-MFs) and a cluster of likely Res-KCs (57). All of these
macrophage populations, as well as cDC2s and bone marrow
monocytes in these mice expressed lower levels of S100a8
and S100a9 encoding the inflammatory protein Calprotectin
compared with the same populations in control mice fed
a normal diet, suggesting they may have anti-inflammatory
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properties (57). Fitting with this, challenge of these mice with an
overdose of paracetamol as a model of acute liver injury resulted
in attenuated disease compared with normal diet fed controls
(57). While a similar response of recruited macrophages and
Res-KCs as observed here (57), would be consistent with the
relative unresponsiveness of total liver macrophages observed
by the Aouadi lab (59), there are a few remaining questions
surrounding this study. The presence of recruited macrophage
populations in the control mice (albeit at lower frequencies than
the NAFLDmice) is rather unexpected especially as some of these
populations seem to be more abundant than the KCs (57). This
raises the question if the control mice are completely healthy? If
so, the question becomes what are these recruited macrophage
populations in the control mice and where are they located?
In addition, a key question is whether the distinct clusters of
recruited macrophages identified truly represent distinct subsets
of macrophages or rather one population existing along a
gradient of activation and/or developmental stages? Regarding
the relative paucity of Res-KCs, while the authors attribute this
to digestion and cell isolation, it raises the question as to whether
the Res-KCs isolated are representative of the total Res-KC pool
in NAFLD/NASH? Moreover, as the origins of these cells were
not studied it remains to be seen if these are truly Res-KCs or if
any infRes-KCs may also be found in the NAFLD/NASH liver.
A second recent study also employing scRNA-seq but this
time using mice fed an amylin (ALMN) diet for 20 weeks to
induce NASH identified distinct clusters of macrophages in the
NASH liver (27). Here one population of recruited macrophages
alongside two KC subsets were identified. The two KC subsets
were identified as KCs based on expression of Cd5l and the two
subsets were distinguished from each other based on expression
of Trem2, Cd9, and Gpnmb (27). The KC population expressing
all of these genes was only present in the NASH condition and
was therefore termed NASH-associated macrophages or NAMs
(27). The expression profile of these NAMs was significantly
different from healthy Res-KCs (27), but the healthy Res-KC
profile was largely maintained in the non-NAM KCs in the
ALMN diet (27), further supporting the idea that at least some
of the Res-KCs may not be altered in NAFLD/NASH. As the
relationship between the two KC subsets identified in the ALMN-
fed mice was not studied (27), it is not clear if the NAMs
represent a recruited population of infRes-KCs, while the non-
NAM KCs represent Res-KCs that do not alter their phenotype
in NASH or if the NAMs are a population of Res-KCs that
have altered their transcriptome due to the NASH environment.
This will of course be important to address as targeting such
macrophages either to assess their functions or later on in the
clinic would require different approaches in each case. Notably
while further study is required to understand the nature of these
macrophage subsets, macrophages with a phenotype similar to
the NAMs have also recently been identified in fibrotic human
livers (28) indicating the potential relevance of these macs in
human disease although not necessarily restricted to NASH as
the name NAMs would suggest. The macrophages identified in
fibrotic human liver tissue were rather termed scar-associated
macrophages (SAMs) and were specifically located around the
fibrotic scars (28). Interestingly the SAMs were distinct from KCs
further highlighting the need to investigate the designation of
NAMs as KCs in the mouse (27).
Despite the advances in understanding macrophage
heterogeneity, an unfortunate feature of these studies is
that it is not always easy to link the subsets identified in the
different studies. This is further complicated by each study
giving a different name to the macrophage populations they
identify. A crucial next step will therefore be to understand
what subsets and profiles are shared across NAFLD/NASH
models and between species and how best to identify them for
downstream functional studies which are still lacking. To try
to align these studies, we have downloaded the data from the
two reports and recreated the tSNE plots (27, 57). While the
tSNE plots are not exact replicates, the same clusters identified
by the two groups could be identified in our recreations based
upon the data provided and the gene lists published for each
population (Figure 2). Expression of a set of markers proposed
as Res-KC markers (Clec4f, Timd4, Cd5l), general macrophage
markers (Adgre1, Fcgr1), monocyte markers (Ccr2 and Ly6c2)
and the markers proposed by the studies (S100a8, S100a9, Cd9,
Trem2, and Gpnmb) were assessed (Figure 2). Interestingly,
the subsets identified in both studies as recruited macrophages
expressed relatively low levels of the macrophage markers
Adgre1 (encoding F4/80) and Fcgr1 (encoding CD64) while
still expressing the monocyte genes Ly6c2 (encoding Ly6C) and
Ccr2, thus perhaps some of these populations may represent
monocytes or monocytes transitioning to macrophages rather
than fully differentiated macrophages (Figure 2). This would
also explain their presence in the healthy controls in the study
from the Tacke lab (57). In terms of expression of the KC-specific
markers, it appears that some of the NAMs do not express
these genes suggesting they may indeed represent Temp-macs
(Figure 2). While further studies will be required to confirm
this, this could indeed suggest that Res-KCs are not significantly
altered in NAFLD/NASH but rather that recruited macs in
NASH have a distinct phenotype from Res-KCs. Regarding the
presence of infRes-macs, in both studies a population of KCs
exist that do not express Timd4 (encoding TIM4), a marker of
long-term residence of KCs in the liver (Figure 2). This could
suggest that like in the MCD-induced NASH model, infRes-KCs
may be generated with an altered profile to Res-KCs. However,
as coverage of Timd4 expression is not always 100% even in
homeostatic conditions (23) and we do not yet fully understand
the signals driving Timd4 expression in KCs, this will need to be
confirmed with fate-mapping studies. While S100a8 and S100a9
expression was not seen in the study from Xiong and colleagues
(Figure 2), what is notable is that the Trem2, Cd9, Gpnmb
signature of NAMs (27), that is also found in macrophages
from human fibrotic tissue (28) can also be found in some
cells in one of the recruited macrophage clusters (mo-mf-II) in
the study from Krenkel et al., notably, in the cells expressing
lower levels of Ly6c2 and higher levels of Adgre1 and Fcgr1
compared with the other populations designated as recruited
macs (Figure 2), suggesting that this may be a truly conserved
signature of Temp-macs in fibrosis. Thus, understanding the
functions of these cells represents an important question for
future studies.
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FIGURE 2 | Comparison of murine scRNA-seq datasets on macrophages in NAFLD/NASH. Publicly available scRNA-seq datasets from (27, 57) were downloaded
and tSNE maps recreated as close to the original as possible with the information provided. The distinct clusters of macrophages and KCs as identified in the original
studies (27, 57) were identified and expression of the indicated markers assessed.
Another key question is if Res-KCs are not functioning
as inflammatory mediators in NAFLD as these recent studies
may suggest, do they play any role? One possibility is that
Res-KCs may function to metabolize the ectopic lipid in NAFLD,
as under homeostatic conditions Res-KCs have been shown
to express a module of genes associated with lipid/cholesterol
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metabolism (11), although this remains to be tested directly. In
line with other roles for Res-KCs, Morgantini et al. proposed
that liver macrophages would function in NAFLD through
their production of non-inflammatory factors including Igfbp7
regulating liver metabolism (59). While an interesting concept
that should be followed up, it will also be important to determine
which of the liver macrophage subsets in NAFLD express Igfbp7
(Res-KCs or recruited macs) and how specific this expression is
across the liver. For example, do any of the niche cells of the
liver such as HSCs and LSECs which express higher levels of
Igfbp7 than Res-KCs under homeostatic conditions (unpublished
data) also express Igfbp7 in NAFLD/NASH and what role does
this play?
Taken together, this significant level of heterogeneity within
the macrophage pool in NAFLD/NASH (Figure 3) highlights
the need to understand the specific functions of the different
macrophage populations identified. In addition, with the
possibility that some monocytes infiltrating the liver in
NAFLD/NASH may give rise to infRes-KCs (Figure 3), this
brings into question the strategy to target all recruited cells in
NAFLD through CCL2 inhibitors (60), as potentially infRes-KCs
and Temp-macs may play distinct roles in disease pathology.
Thus, further investigation into the biology of this heterogeneity
is warranted, especially in terms of understanding the functional
contribution of the conserved subset of putative Temp-macs
expressing Cd9, Trem2, and Gpnmb found across multiple
models and in human fibrotic tissue as well as the location of
these subsets in the tissue and their interactions with the local
niche. Of note, one study in Trem2 KO mice fed a western diet
found reduced pathology in the KOs compared withWT controls
(61). While this was attributed to macrophages in the adipose
tissue (61) (see below) it is also possible that this phenotype was
due to the lack of Trem2-expressing macrophages in the fatty
liver, further highlighting the need for functional studies with
these populations.
MACROPHAGE SUBSETS IN OBESE
ADIPOSE TISSUE
The adipose tissue consists mainly of adipocytes and functions
as an energy store but also produces hormones, for example
those regulating lipid metabolism and hunger satiety. Adipose
tissue macrophages (ATMs) are spread throughout the adipose
tissue with a significant proportion in lean mice being found
associated with the vasculature and hence recently termed
vasculature-associated macrophages or VAMs (62). VAMs are
identified on the basis of their expression of CD206 and
CD11b and can be subdivided into two subpopulations (VAM1
and VAM2) based on MHCII and TIM4 expression, with
VAM2s expressing higher levels of TIM4 (62). In addition
a population of CD206intCD11b+CD64+CD11c− pre-VAMs
and CD206intCD11b+CD11c+CD64+ double positive (DP)
macrophages were also identified in this study although their
localization was not investigated (62). Regarding ATM origins,
although initially not included in macrophage fate mapping
studies, recently, it was suggested that, under homeostatic
conditions, Res-ATMs derive from yolk-sac progenitors (63).
However, BM progenitors were also shown to engraft and
give rise to Res-ATMs as ∼40% of ATMs were derived from
the BM following congenic donor BM transplantation (63)
moreover whether fetal liver monocytes can contribute to the
Res-ATM pool remains to be investigated. This contribution
of BM monocytes to the total homeostatic Res-ATM pool in
lean mice has also recently been confirmed by fate mapping
of ATMs using Ms4a3-tagging (61). However, how similar the
BM derived Res-ATMs are compared with the embryonic-
derived Res-ATMs remains to be investigated. Notably, upon
discriminating between VAMs, pre-VAMs and DP adipose tissue
macs, Silva et al. identified VAMs to be primarily embryonically
derived with only minimal input from BMmonocytes while pre-
VAMs and DP macrophages were largely derived from the BM
(62), suggesting that the turnover of the VAMs is relatively slow
with between 1 and 10% of the VAMs being monocyte-derived 60
days after shielded irradiation and congenic donor BM transplant
when donor BM input in blood monocytes is normalized to
100% (62). Given the relationship between TIM4 expression and
residency time of Res-KCs in the liver (11), as VAM2s had lower
levels of chimerism than VAM1s and also expressed TIM4 it is
tempting to speculate that VAM2s may be the Res-ATMs that
have been in the tissue the longest, while TIM4lo VAM1s may
be younger recruits (62). Notably, Res-ATMs were also found
to proliferate locally in lean mice (63). In addition to local
proliferation, Res-ATMnumbers are alsomaintained through the
action of cytotoxic type 1 ILCs in adipose tissue which control
ATM numbers (64).
In obese adipose tissue, adipocytes enlarge and subsequently
die. In response, the number of ATMs is dramatically increased
from∼10% of all immune cells in lean mice to∼50% (65, 66), of
which, many are found localized with dead adipocytes forming
crown-like structures (CLS) in both humans and mice, allowing
the macrophages to surround and engulf the adipocytes (67–
69). The increase in ATMs derives partially from the recruitment
of new macs in a CCL2 dependent manner, and as in NAFLD,
it was these recruited macs that were thought to drive local
inflammation and insulin resistance (70–72). In addition, local
proliferation of ATMs, specifically those located in the crown-
like structures (CLS) has also been reported to contribute to
the increase in ATM number in obesity (73–75). Until recently
the exact nature of these ATMs in obese adipose tissue was
unclear. It had been established that obesity led to a switch in
macrophage phenotype from amoreM2-like phenotype to aM1-
like phenotype (76), with the caveats of using this nomenclature
in vivo withstanding (Figure 1). However, it was unclear if this
represented the recruitment of a distinct population of Temp-
ATMs or infRes-ATMs with an M1-like phenotype in obesity or
if this also represented plasticity of Res-ATMs. In addition, M1-
like cells were typically associated with increased inflammation
and a negative outcome however, it is also possible that the
recruited ATMs in obese adipose tissue may be beneficial for
the tissue, adopting a profile that enables the clearance of
dying adipocytes (7). Recently, many groups have begun to
address these questions using scRNA-seq and multi-parameter
flow cytometry approaches (61, 62, 77–80). Hill and colleagues
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FIGURE 3 | Macrophage Heterogeneity in NAFLD and NASH. This figure demonstrates possible macrophage heterogeneity present during NAFLD/NASH. During
steady state the main macrophage population present in the liver is resident Kupffer Cells (Res-KCs) which are in close contact with the liver endothelial cells (LSECs),
stellate cells and hepatocytes. Healthy monocytes pass through the blood flow of the liver sinusoids daily and typically do not engraft unless the niche becomes
available. During NAFLD there is an increase in lipids in the liver and subsequently hepatocytes become lipid laden. The lipemic environment also contributes to stellate
cell and endothelial cell activation likely altering the macrophage niche. Multiple populations of macrophages have been identified in the NAFLD liver but the relationship
between them remains unclear. For example, does the lipemic environment activate the Res-KCs (activated Res-KCs) or do monocytes (which have been shown to
have an altered transcriptional profile) recruited to the liver in NAFLD engraft and give rise to infRes-KCs, with a similar profile to Res-KCs but showing signs of the
altered environment. Additionally, in NAFLD, monocytes have been shown to engraft and generate Temp-macs, although how distinct these are from either Res-KCs,
activated Res-KCs or InfRes-KCs remains to be studied. For example, an interesting population of macrophages expressing Cd9, Trem2, and Gpnmb in murine NASH
and human fibrotic livers have been described (27, 28) but whether these represent activated Res-KCs, infRes-KCs or Temp-macs remains to be formally examined.
identified 2 subsets of F4/80+CD64+ ATMs distinguished on the
basis of CD9 expression as well as a population of Ly6C+CD11b+
monocyte-like cells (78). While the monocyte-like cells were
increased in frequency in obese compared with lean adipose
tissue, CD9+ ATMs were restricted to the adipose tissue of the
mice fed a HFD and were also identified in obese patient adipose
tissue (78). Notably, some of the Ly6C monocytes also expressed
CD9 suggesting these could be the precursors for the CD9+
ATMs (78). Both populations were shown to derive from the BM
using a chimera model, however the origins of the CD9− ATMs
were not assessed (78). The authors found the CD9+ ATMs to be
located in the CLSs, where they had an increased lipid content
and a transcriptional profile enriched for proinflammatory and
metabolic genes when compared with the Ly6C monocytes.
However, how this compared with the CD9− ATMs was not
investigated. Fitting with the more complex in vivo environment,
the CD9+ ATM transcriptional profile was clearly distinct from
M1 or M2 profiles (78).
After identifying the VAM, pre-VAM, and DP mac
populations in lean mice using flow cytometry, Silva and
colleagues then put the mice on a HFD for 20 weeks. This led
to an increase in all ATM populations identified with the largest
increase observed in the DP macs (62). Interestingly, these DP
macs were reported to correlate with the CD9+ macs identified
by Hill and colleagues (62), however, Silva and colleagues also
reported increased CD9 expression in the VAMs upon HFD
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FIGURE 4 | Comparison of murine scRNAseq datasets on macrophages in obese adipose tissue. Publicly available scRNA-seq datasets from (61, 80) were
downloaded and tSNE maps recreated as close to the original as possible with the information provided. The distinct clusters of macrophages and KCs as identified in
the original studies (61, 80) were identified and expression of the indicated markers assessed.
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FIGURE 5 | Macrophage heterogeneity in obese adipose tissue. This figure demonstrates possible macrophage heterogeneity present in healthy and obese adipose
tissue. In healthy tissue, resident macrophages (Res-ATMs) have been described which express genes suggesting they would be found close to vasculature
(61, 62, 80). In one study these were hence termed vascular associated macrophages (VAMs) and could be identified in two subsets those expressing TIM4 and
intermediate levels of MHCII (VAM2) and those with a TIM4loMHCIIhi profile (VAM1) (62). In addition a population of macrophages deriving from monocytes and
expressing CD11c and CD64 termed double-positive macrophages (DP-macs) were also described, however their precise nature remains to be seen as a distinct
subset of such macrophages was not observed in healthy adipose tissue in scRNA-seq studies (61, 80). Monocytes are also found in healthy adipose tissue. In obese
adipose tissue, the number of monocytes and macrophages dramatically increases. In terms of subsets, Res-ATMs remain, however, exactly how distinct these are
from those in healthy tissue remains a question. Some changes in transcriptional profile were identified in VAM1s and VAM2s but whether these represent activated
(Continued)
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FIGURE 5 | Res-ATMs or infRes-ATMs remains to be seen. Whether some Res-ATMs exist that do not react to the obese environment also remains a question but
notably in both scRNA-seq studies, Res-ATMs were identified in the same cluster with those isolated from lean mice (61, 80) suggesting that at least a proportion of
the population may not react extensively to the environment. In addition, a population of Cd9, Trem2 Gpnmb, Spp1 expressing lipid-associated macrophages (LAMs)
have also been identified forming crown-like structures in obese adipose tissue. These represent a unique population in the scRNA-seq studies found only in obese
adipose tissue. In addition a population of phagocytic macrophages have also been described in obese adipose tissue and being expanded calorie restricted obese
mice (80) that have a phenotype similar to DP-macs but also show some overlap with CD9+ Temp-macs (non-LAMs) in obese adipose tissue. Thus, the exact nature
of these cells also requires further analysis.
feeding suggesting that the CD9+ population identified by Hill
may include these two subsets (62). In another study, Jaitin et al.
identified 3 CD63+ ATM clusters using scRNA-seq (61). One
cluster, termed Mac1, were the only ATM population present
in lean mice and hence were identified as the Res-ATMs (61).
This Mac1 cluster contained Cd9− ATMs that expressed genes
previously associated with perivascular macrophages in the lung
interstitium includingCd163, Lyve1, andRetnla (61, 81), and thus
likely correspond to the steady state VAMs (62). Indeed upon
downloading the data and regenerating the plots to compare the
studies (Figure 4), expression of the proposed VAM markers
Mrc1 (encoding CD206), Shglb3 and Timd4 (62) was observed
in this Lyve1-expressing Mac1 population, although Shglb3
expression was not restricted to these cells (Figure 4). Notably
no second cluster of DP macs was identified in lean conditions
again questioning if these truly represent a distinct subset of
macrophages or rather a distinct developmental stage/monocyte
intermediate given that BM monocytes were found to engraft
(albeit slowly) into the VAMs (61, 62). The other two clusters
(Mac2 and Mac3) identified by Jaitin et al. expressed Cd9 and
were only found in obese mice, either due to feeding a HFD
or genetic defects (db/db obese mice) (61). The Mac2 cluster
also expressed the genes encoding surface markers proposed for
VAMs (Figure 4) and thus could represent the CD9+ VAMs
reported to be present in obese adipose tissue (62). However,
the Mac2 cluster lacked expression of the genes associated with
being located in a vascular niche and rather CD9+ macrophages
(Mac2 and Mac3) were found to be located in the CLSs (61). If
the Mac2 cluster do represent CD9+ VAMs, they could be seen
as either activated Res-ATMs or infRes-ATMs. As fate-mapping
studies using the Ms4a3-CrexTdTomato reporter mice found
an increased contribution of monocytes to the total CD63+
ATM pool after 16 weeks of HFD feeding compared with mice
fed normal chow for the same period (61), this could suggest
that these would be infRes-ATMs, however, this needs to be
tested. Interestingly, the Mac3 cluster, while expressing some
genes encoding VAM markers, also expressed Itgax (encoding
CD11c) and Mrc1 expression (encoding CD206) was lower than
in other Mac populations which could suggest that these are the
DP macs identified by Silva and colleagues but then restricted
to the obese adipose tissue in this study (61, 62). Overall, while
there is potential to align these populations, it is clear that
further analysis combining protein and mRNA expression at
the single cell level will be necessary to completely align the
subsets/clusters identified in these studies and to determine
which represent infRes-Macs and Temp-macs in the obese tissue.
Further analysis of the differences between the 3 ATM clusters
in the study by Jaitin et al. identified the Mac3 cluster to be
enriched for a number of genes associated with lipid metabolism
and phagocytosis, including Trem2, Gpnmb, Lipa, Lpl, Cd36,
and Fabp4 and thus these cells were termed lipid-associated
macrophages (LAMs) (61). Although some Trem2 expression
was also observed in the Mac2 population (61). Moreover, the
LAMs also expressed the chemokine osteopontin (encoded by
Spp1) and crucially were also found in human obese adipose
tissue (61).
Simultaneously, two additional studies performed scRNAseq
studies in obese adipose tissue. These studies identified multiple
clusters of macrophages in obese mice including those they
termedmajormacs, activatedmacs, residentmacs and phagocytic
macs (79, 80). Major macs were the subset that were most
significantly expanded in obese conditions (79, 80) while
phagocytic macs were only found in obese adipose tissue and
were further expanded upon caloric restriction in obese mice
(80). Intriguingly, a cluster within the major macs were enriched
for expression of Cd9, Trem2, Gpnmb, and Spp1 (80) (Figure 4),
markers of the LAMs identified by Jaitin et al. (61). As lean
controls from the same facility were not included in this study
it will be interesting to examine if this cluster of major macs
are indeed restricted to obese conditions. Similarly, it will
be interesting to determine the longevity of this cluster and
expression of these genes in more long-term caloric restriction
studies as some macs with this LAM phenotype were also found
in this study after 2 weeks of caloric restriction (Figure 4) (80).
The presence of phagocytic macs in obese and caloric
restricted mice but not lean mice is also interesting (80). A
comparison between these and the macrophage subsets identified
by Silva and colleagues (62), found that these most closely
resembled the DP macs (80), a population of cells difficult to
accurately identify in the dataset from Jaitin et al. (61). The
two markers proposed to identify the phagocytic macs based
on mRNA expression but also at the protein level were Pecam1
(encoding CD31) and Fcgr4 (80). While Pecam1 expression was
low in both datasets (Figure 4), Fcgr4 was indeed enriched in
the phagocytic macs from the Weinstock study and was also
expressed by the Mac2 cluster in the study from Jaitin et al.
(Figure 4). As this cluster is only found in obese adipose tissue
fitting with the description from Weinstock et al. perhaps these
represent the phagocytic macrophages however, this Mac2 subset
does not express Itgax (encoding CD11c) suggesting they are
likely not the DP macs as described above (at least based
on mRNA expression), and thus further comparison of these
datasets is warranted. As the phagocytic macs are expanded in
caloric restriction, it is also possible that this subset does not
exist in the dataset from Jaitin et al., but then the suggestion
that the phagocytic macs could be the DP macs should be further
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examined (61, 62, 80). Notably, some monocytes in the study by
Jaitin et al. also expressed Fcgr4 further questioning if the DP
macs in lean adipose tissue represent a distinct subset or rather
a developmental intermediate (Figure 4).
While there is still much to learn regarding the macrophage
clusters in obese adipose tissue, there is clearly heterogeneity
within adipose tissue macs (Figure 5) and a consensus for
identifying these populations has not yet been reached.
Nevertheless, the LAMs represent a very interesting population.
Firstly, they do not appear to be restricted to adipose tissue,
as the LAM profile was found to be highly similar to disease-
associated microglia (DAMs) found in the brain in Alzheimer’s
disease (82) suggesting this may be a general of phenotype of
macrophages that have to process significant levels of ectopic
lipid. Indeed the transcriptional profiles of NAMs (27) and SAMs
(28) identified in the NASH or fibrotic liver also bear some
resemblance to the LAMs, although exactly how similar these are
remains to be studied. Moreover, a population of macrophages
in CLSs with a similar transcriptional profile to LAMs including
Spp1, Fabp5, Lpl, Lipa, and Cd36 expression was identified during
de novo lipogenesis induced by β3-adrenergic receptor activation
using scRNAseq (77). De novo lipogenesis in WAT requires
macrophages to clear dead/dying white adipocytes suggesting
that this profile could be driven by uptake of adipocytes and
dying cells and a need for lipid metabolism. Interestingly, this
LAM profile is distinct from Res-KCs despite their expression
of genes involved in lipid metabolism (21, 23) and LDAMs,
which were identified on the basis of their lipid content and
unique transcriptional profiles (26), thus perhaps the signature is
governed by more than the presence of lipid. It will be intriguing
to understand which other diseases induce such a profile in the
recruited macs across tissues. In addition, functionally the LAMs
appear to be an interesting population. Given their expression
of Trem2 within the adipose tissue, the role of Trem2 in the
LAMs was also investigated using Trem2-deficient mice (61).
Notably, LAMs were not identified in the adipose tissue of
Trem2-deficient mice fed the HFD, with ATMs retaining the
signatures of the macs found in clusters 1 and 2, suggesting
that TREM2 signaling is specifically required for the LAM
profile (61). Notably, the Trem2−/− ATMs also had decreased
lipid content and the formation of CLSs was abrogated in
the absence of Trem2-expressing ATMs (61). This correlated
with adipocyte hypertrophy and increased weight gain/body
fat accumulation and increased signs of metabolic syndrome
including glucose intolerance, elevated serum insulin levels
and hypercholesterolemia (61). Conversely, deletion of Netrin-
1 in macrophages (driven by LysM-Cre) resulted in a partial
protection from diet-induced obesity and improved insulin
sensitivity coupled with an increase in adipocyte beiging markers
(79). This improved outcome correlated with alterations in the
macrophage populations including an increase in the proportion
of major macrophages compared with the other mac populations
(although the number of macrophages in total was reduced
compared withWTmice fed the HFD) (79). While an increase in
genes associated with lipid handling in the macrophage pool and
a decrease in pro-inflammatory lipid mediators were attributed
to the improved outcome on the diet (79), as the major mac
population appears to include the LAMpopulation (80) andmacs
of this phenotype have been implicated in de novo lipogenesis
(77), it is tempting to speculate that this population maybe
also plays a role in the improved response to the HFD in the
myeloid-specificNetrin-1-deficientmice (79).While this remains
to be investigated, it is plausible that, contrary to the original
idea that these recruited macs would be detrimental for disease,
LAMs may be required to help restrict disease progression.
Given that these results were obtained in either full body KOs
or chimeras (Trem2) or in all myeloid cells (Netrin-1) and as
macs with similar profiles have been identified in other tissues,
it will now be important to examine the role of TREM2 and the
expression and function of NETRIN-1 in the distinctmacrophage
populations in adipose tissue and liver to determine exactly which
macrophage populations are important for these differences in
disease pathology.
CONCLUDING REMARKS
Taken together, it is clear that there is significant heterogeneity
within the macrophage pool in both obese adipose tissue and
the fatty liver. This heterogeneity is made up of different subsets
(Res-macs, infRes-macs and Temp-macs) but also likely include
developmental intermediates and/or different activation states of
the same cell subset.While single-cell technologies have helped us
to understand this heterogeneity, questions regarding the specific
functions of these different subsets and/or the precise definition
of distinct subsets remain which will be important to understand
in the coming years. Studies using full body KOs and chimeras are
helping to shed light on the functions of the different populations,
but further work is still required using cell-type specific KOs
before we can truly assess the roles of one population over
another so that we can better understand which populations we
may need to target with new therapeutic approaches.
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